135 related articles for article (PubMed ID: 2818278)
1. Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial.
Kass MA; Gordon MO; Hoff MR; Parkinson JM; Kolker AE; Hart WM; Becker B
Arch Ophthalmol; 1989 Nov; 107(11):1590-8. PubMed ID: 2818278
[TBL] [Abstract][Full Text] [Related]
2. Timolol treatment prevents or delays glaucomatous visual field loss in individuals with ocular hypertension: a five-year, randomized, double-masked, clinical trial.
Kass MA
Trans Am Ophthalmol Soc; 1989; 87():598-618. PubMed ID: 2562546
[TBL] [Abstract][Full Text] [Related]
3. Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial (1).
Kass MA; Gordon MO; Hoff MR; Parkinson JM; Kolker AE; Hart WM; Becker B
J Glaucoma; 1993; 2 Suppl A():1-2. PubMed ID: 19920456
[TBL] [Abstract][Full Text] [Related]
4. Decrease of optic disc cupping and pallor of ocular hypertensives with timolol therapy.
Schwartz B; Lavin P; Takamoto T; Araujo DF; Smits G
Acta Ophthalmol Scand Suppl; 1995; (215):5-21. PubMed ID: 8846250
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of timolol therapy in ocular hypertension: a double-masked, randomised trial.
Heijl A; Bengtsson B
Graefes Arch Clin Exp Ophthalmol; 2000 Nov; 238(11):877-83. PubMed ID: 11148810
[TBL] [Abstract][Full Text] [Related]
6. A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter clinical trial. Chronic Brimonidine Study Group.
Schuman JS; Horwitz B; Choplin NT; David R; Albracht D; Chen K
Arch Ophthalmol; 1997 Jul; 115(7):847-52. PubMed ID: 9230823
[TBL] [Abstract][Full Text] [Related]
7. Effects of Topical Bimatoprost 0.01% and Timolol 0.5% on Circadian IOP, Blood Pressure and Perfusion Pressure in Patients with Glaucoma or Ocular Hypertension: A Randomized, Double Masked, Placebo-Controlled Clinical Trial.
Oddone F; Rossetti L; Tanga L; Berardo F; Ferrazza M; Michelessi M; Roberti G; Manni G; Centofanti M
PLoS One; 2015; 10(10):e0140601. PubMed ID: 26484767
[TBL] [Abstract][Full Text] [Related]
8. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.
Sonty S; Mundorf TK; Stewart JA; Stewart WC
Clin Ther; 2009 Oct; 31(10):2063-71. PubMed ID: 19922877
[TBL] [Abstract][Full Text] [Related]
9. The Low-pressure Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients.
Krupin T; Liebmann JM; Greenfield DS; Rosenberg LF; Ritch R; Yang JW;
Ophthalmology; 2005 Mar; 112(3):376-85. PubMed ID: 15745762
[TBL] [Abstract][Full Text] [Related]
10. A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data.
Nordmann JP; Mertz B; Yannoulis NC; Schwenninger C; Kapik B; Shams N;
Am J Ophthalmol; 2002 Jan; 133(1):1-10. PubMed ID: 11755834
[TBL] [Abstract][Full Text] [Related]
11. Effect of timolol maleate on the retinal circulation of human eyes with ocular hypertension.
Grunwald JE
Invest Ophthalmol Vis Sci; 1990 Mar; 31(3):521-6. PubMed ID: 2138590
[TBL] [Abstract][Full Text] [Related]
12. The Ocular Hypertension Treatment Study: design and baseline description of the participants.
Gordon MO; Kass MA
Arch Ophthalmol; 1999 May; 117(5):573-83. PubMed ID: 10326953
[TBL] [Abstract][Full Text] [Related]
13. Enhanced acute ocular hypotensive response to timolol with dexamethasone treatment.
Rom M; Schwartz B; Bealka N
J Glaucoma; 1997 Apr; 6(2):111-6. PubMed ID: 9098819
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular effects of topical carteolol hydrochloride and timolol maleate in patients with ocular hypertension and primary open-angle glaucoma. Night Study Group.
Netland PA; Weiss HS; Stewart WC; Cohen JS; Nussbaum LL
Am J Ophthalmol; 1997 Apr; 123(4):465-77. PubMed ID: 9124243
[TBL] [Abstract][Full Text] [Related]
15. Diversity of response of optic nerve head circulation to timolol maleate in gel-forming solution.
Netland PA; Schwartz B; Feke GT; Takamoto T; Konno S; Goger DG
J Glaucoma; 1999 Jun; 8(3):164-71. PubMed ID: 10376255
[TBL] [Abstract][Full Text] [Related]
16. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
[TBL] [Abstract][Full Text] [Related]
17. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.
Kass MA; Heuer DK; Higginbotham EJ; Johnson CA; Keltner JL; Miller JP; Parrish RK; Wilson MR; Gordon MO
Arch Ophthalmol; 2002 Jun; 120(6):701-13; discussion 829-30. PubMed ID: 12049574
[TBL] [Abstract][Full Text] [Related]
18. Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
Michaud JE; Friren B;
Am J Ophthalmol; 2001 Aug; 132(2):235-43. PubMed ID: 11476685
[TBL] [Abstract][Full Text] [Related]
19. Lack of long-term drift in timolol's effectiveness in patients with ocular hypertension.
Bengtsson B; Heijl A
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2839-42. PubMed ID: 11687526
[TBL] [Abstract][Full Text] [Related]
20. Steady-state pattern electroretinogram following long term unilateral administration of timolol to ocular hypertensive subjects.
Nesher R; Trick GL; Kass MA; Gordon MO
Doc Ophthalmol; 1990 Sep; 75(2):101-9. PubMed ID: 2276311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
